Your showerhead slime is alive

 

Boulder, Col., USA (November 1, 2018) – The day after Halloween, something scary may still lurk inside your showerhead. Researchers at CIRES have identified Mycobacterium as the most abundant genus of bacteria growing in the slimy “biofilm” that lines the inside of residential showerheads–and some of those bacteria can cause lung disease.

In a new study, they report that mycobacteria are more prevalent in the United States than in Europe, thrive more in municipal tap water than in well water, and are especially common in geographical “hot spots” where certain types of lung disease caused by mycobacteria are also common.

It’s important to understand routes of mycobacterial exposure, especially in the household. We can learn a lot from studying the biofilm that accumulates inside your showerhead, and the associate water chemistry,” said Matt Gebert, CIRES researcher and lead author of the new study published this week in the American Society for Microbiology’s journal mBio. “There is a lot of interesting ecology at work, and it allows us to begin to understand how it can impact human health.”

The research team, CIRES Fellow and Professor of Ecology and Evolutionary Biology at CU Boulder Noah Fierer’s group, began this work in 2017, funded partially by an CIRES Innovative Research Program grant. The team analyzed DNA collected from 656 household showers in the United States and 13 countries in Europe. Citizen scientists swabbed the inside of their showerheads with specialized kits, and mailed the “biofilm” samples to Boulder.

By harnessing DNA sequencing technology, the researchers were able to identify which bacterial species that lived in showerhead slime, and how abundant they were. Mycobacteria were far more abundant in showerheads receiving municipal tap water than in those receiving well water, as well as more abundant in U.S. households versus European.

These patterns are probably driven in part by differences in the use of chlorine disinfectants, the team reported. Mycobacteria tend to be somewhat resistant to the chlorine-based disinfectants used more heavily in the United States than in Europe–so in Europe, other bacterial species may be better able to thrive and outcompete the disease-causing strains.

Showerhead materials seemed to matter, too, with more mycobacteria in metal showerheads than in plastic ones–plastic leaches some chemicals that support diverse bacterial communities, possibly preventing the mycobacteria from becoming too abundant.

When the researchers mapped out where potentially pathogenic mycobacteria thrived, the maps revealed “hot spots” that roughly match regions where a nontuberculous mycobacterial (NTM) lung disease is most prevalent–parts of Southern California, Florida, and New York, highlighting the potentially important role of these showerhead bacteria in disease transmission.

There is a fascinating microbial world thriving in your showerhead and you can be exposed every time you shower,” Fierer said. “Most of those microbes are harmless, but a few are not, and this kind of research is helping us understand how our own actions–from the kinds of water treatment systems we use to the materials in our plumbing–can change the makeup of those microbial communities.”

“In terms of what’s next, we’re hoping to begin to explore, beyond identification and abundance, what is causing this striking geographic variation within the genus Mycobacterium, and what is potentially driving these ‘hot spots’,” said Gebert.

“And don’t worry,” he added. “There is definitely no reason to fear showering.”

 


University of Colorado at Boulder, 01.11.2018(tB).

Schlagwörter: , ,

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 
Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung